Geraniin Attenuates Lipopolysaccharide-Induced Cognitive Impairment in Mice by Inhibiting Toll-Like Receptor 4 Activation
Authors:
- Dongmei WangDWDongmei Wang
- Xiaohui DongXDXiaohui Dong
- Bei WangBWBei Wang
- Yumei LiuYLYumei Liu
- Sanqiang LiSLSanqiang Li
- 28 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 67 (36) , 10079-10088
Abstract
Geraniin has been reported to possess potent anti-inflammatory properties and to modulate the macrophage polarization. This study sought to evaluate the protective effects and underlying mechanisms of geraniin on lipopolysaccharide (LPS)-induced neuroinflammation and neurobiological alternations as well as cognitive impairment. Daily intragastrical administration with geraniin (20 mg/kg per day) for 14 days significantly prolonged the duration in the target quadrant (26.53 ± 2.03 vs 37.09 ± 3.27 %, p < 0.05) and increased crossing-target number (1.93 ± 0.22 vs 3.08 ± 0.17, p < 0.01) in the probe test of LPS-treated mice. Geraniin also ameliorated LPS-elicited neural/synaptic impairments and decreased levels of LPS-induced Aβ generation (p < 0.05), amyloid precursor protein (APP) (p < 0.05) and β-site amyloid precursor protein cleavage enzyme 1 (BACE1) (p < 0.05). Furthermore, Geraniin suppressed the production of proinflammatory cytokines including tumor necrosis factor alpha (TNF-α) (9.85 ± 0.58 vs 5.20 ± 0.52 pg/mg protein, p < 0.01), interleukin (IL)-1β (16.31 ± 0.67 vs 8.62 ± 0.46 pg/mg protein, p < 0.01), and IL-6 (12.12 ± 0.45 vs 7.43 ± 0.32 pg/mg protein, p < 0.05), and inhibited glial cell activation. Moreover, geraniin effectively polarized the microglia towards an anti-inflammatory M2 phenotype. Further study revealed that geraniin targeted Toll-like receptor 4 (TLR4)-mediated signaling and decreased the production of proinflammatory cytokines in BV-2 microglial cells. These results indicate that geraniin mitigates LPS-elicited neural/synaptic neurodegeneration, amyloidogenesis, neuroinflammation, as well as cognitive impairment, and suggest geraniin as a therapeutic option for neuroinflammation-associated neurological disorders such as Alzheimer's disease.Keywords
Funding Information
- National Natural Science Foundation of China (U1804174, 81601225)
- Henan Province (192102310081, 184100510006, 20HASTIT044, 18IRTSTHN026)
This publication has 45 references indexed in Scilit:
- A new method for Schwann-like cell differentiation of adipose derived stem cellsNeuroscience Letters, 2013
- Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory propertiesThe Journal of Nutritional Biochemistry, 2013
- GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microgliaJournal of Neuroinflammation, 2012
- Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo modelsJournal of Neuroinflammation, 2012
- Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E2 Production in AstrocytesJournal of Biological Chemistry, 2012
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- TLR4/MyD88/PI3K interactions regulate TLR4 signalingJournal of Leukocyte Biology, 2009
- Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)Journal of Neuroimmunology, 2009
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007